Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate
Vadadustat is an investigational drug belonging to a class known as hypoxia-inducible prolyl hydroxylase inhibitors (HIF-PHIs) for the treatment of anemia in chronic kidney disease.
Watch video Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate online without registration, duration hours minute second in high quality. This video was added by user AJMCtv 23 October 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,823 once and liked it 12 people.